R1 Therapeutics
Pre-clinicalR1 Therapeutics is developing innovative, category-defining therapeutics for patients with kidney disease.
Founded
2020
Focus
Small Molecules
About
R1 Therapeutics is developing innovative, category-defining therapeutics for patients with kidney disease.
Funding History
2Total raised: $62M
Series A$50MCormorant Asset ManagementOct 15, 2022
Seed$12MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile